BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12610181)

  • 1. Public attitudes toward participation in cancer clinical trials.
    Comis RL; Miller JD; Aldigé CR; Krebs L; Stoval E
    J Clin Oncol; 2003 Mar; 21(5):830-5. PubMed ID: 12610181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public attitudes regarding willingness to participate in medical research studies.
    Trauth JM; Musa D; Siminoff L; Jewell IK; Ricci E
    J Health Soc Policy; 2000; 12(2):23-43. PubMed ID: 11184441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials: time for action.
    Cassileth BR
    J Clin Oncol; 2003 Mar; 21(5):765-6. PubMed ID: 12610171
    [No Abstract]   [Full Text] [Related]  

  • 4. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
    Townsley CA; Chan KK; Pond GR; Marquez C; Siu LL; Straus SE
    BMC Cancer; 2006 Feb; 6():34. PubMed ID: 16466574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers.
    Melisko ME; Hassin F; Metzroth L; Moore DH; Brown B; Patel K; Rugo HS; Tripathy D
    Clin Breast Cancer; 2005 Apr; 6(1):45-54. PubMed ID: 15899072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitude towards clinical trials: results of a survey of persons interested in research.
    Ohmann C; Deimling A
    Inflamm Res; 2004 Aug; 53 Suppl 2():S142-7. PubMed ID: 15338066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.
    Sateren WB; Trimble EL; Abrams J; Brawley O; Breen N; Ford L; McCabe M; Kaplan R; Smith M; Ungerleider R; Christian MC
    J Clin Oncol; 2002 Apr; 20(8):2109-17. PubMed ID: 11956272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
    Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
    J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation in a women's breast cancer risk counseling trial. Who participates? Who declines? High Risk Breast Cancer Consortium.
    Rimer BK; Schildkraut JM; Lerman C; Lin TH; Audrain J
    Cancer; 1996 Jun; 77(11):2348-55. PubMed ID: 8635106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Pediatric Research Participation Questionnaire for Measuring Attitudes Toward Cancer Clinical Trials Among Adolescents and Young Adults.
    Barakat LP; Stevens E; Li Y; Reilly A; Deatrick JA; Goldstein NE; Schwartz LA
    J Adolesc Young Adult Oncol; 2019 Aug; 8(4):423-433. PubMed ID: 31025898
    [No Abstract]   [Full Text] [Related]  

  • 11. Exploring research participation among cancer patients: analysis of a national survey and an in-depth interview study.
    Mc Grath-Lone L; Day S; Schoenborn C; Ward H
    BMC Cancer; 2015 Sep; 15():618. PubMed ID: 26341736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes and views of the general public towards research participation.
    Burns KE; Magyarody N; Jiang D; Wald R
    Intern Med J; 2013 May; 43(5):531-40. PubMed ID: 21241441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
    Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
    Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Maryland cancer patient participation in national cancer institute-supported cancer treatment clinical trials.
    Baquet CR; Ellison GL; Mishra SI
    J Clin Oncol; 2008 Jul; 26(20):3380-6. PubMed ID: 18612153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Italian health consumers feel about clinical research: a questionnaire survey.
    Mosconi P; Poli P; Giolo A; Apolone G
    Eur J Public Health; 2005 Aug; 15(4):372-9. PubMed ID: 16014662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying motivations and barriers to patient participation in clinical trials.
    Jones JM; Nyhof-Young J; Moric J; Friedman A; Wells W; Catton P
    J Cancer Educ; 2006; 21(4):237-42. PubMed ID: 17542716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altruism among participants in cancer clinical trials.
    Truong TH; Weeks JC; Cook EF; Joffe S
    Clin Trials; 2011 Oct; 8(5):616-23. PubMed ID: 21813584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes toward clinical trials among patients and the public.
    Cassileth BR; Lusk EJ; Miller DS; Hurwitz S
    JAMA; 1982 Aug; 248(8):968-70. PubMed ID: 7097966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials.
    Fern LA; Lewandowski JA; Coxon KM; Whelan J;
    Lancet Oncol; 2014 Jul; 15(8):e341-50. PubMed ID: 24988937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Educating Hispanics About Clinical Trials and Biobanking.
    Rangel ML; Heredia NI; Reininger B; McNeill L; Fernandez ME
    J Cancer Educ; 2019 Dec; 34(6):1112-1119. PubMed ID: 30112612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.